OR

Browse By

Induced pluripotent stem cell derived cardiomyocytes: a new therapy for 'no-option' end stage heart failure (MRFF Stem Cell Therapies grant from University of Sydney). (2021–2026)

Grant type:
University of Sydney
Researchers:

  • Professor Peter Gray

    Professorial Research Fellow
    Australian Institute for Bioengineering and Nanotechnology

  • Associate Professor Nathan Palpant

    National Heart Foundation of Austra
    Institute for Molecular Bioscience

  • Dr Andrew Prowse

    Facility Manager - StemCore
    Australian Institute for Bioengineering and Nanotechnology
    Project Lead
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
The University of Sydney